This combination of phenotypes then confers an advantage because it increases extracellular matrix (ECM) degradation to facilitate invasion, induces death in normal cells, increases vascular endothelial growth factor (VEGF) release, and reduces the effectiveness of cytotoxic T cells in generating an immune response to tumor antigens. The gene discussed is VEGFA; the disease is neoplasm.